The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis
This 3-year follow-up study investigated the efficacy and side effects of the levonorgestrel intrauterine system for treating dysmenorrhea related to adenomyosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
The paper reports a 3-year follow-up of the levonorgestrel intrauterine system (LNG-IUS) used to treat dysmenorrhea associated with adenomyosis, focusing on both efficacy and side effects over time. It is a clinical follow-up design, but the provided text does not include participant characteristics, the outcome measures used, the magnitude/direction of symptom changes, or the specific side effects observed at 3 years. A major limitation is that the full results and any stated caveats are not available in the excerpt provided, preventing confirmation of key findings. This paper is centrally about adenomyosis — it follows LNG-IUS treatment outcomes for dysmenorrhea associated with adenomyosis over a 3-year period.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Full text
500 characters
· extracted from
oa-doi-fallback
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (1)
Cited by (5)
- Contraceptive Use of Levonorgestrel Intrauterine System: Case Series 2020
- Efficacy of the levonorgestrel-releasing intrauterine device is associated with different subtypes of adenomyosis: a retrospective study 2020
- Clinical Efficacy and Safety of Major Uterine Wall Resection and Reconstruction of the Uterus Combined with LNG-IUS for the Treatment of Severe Adenomyosis 2019
- Clinical efficacy of levonorgestrel releasing intrauterine system for the treatment of adenomyosis in perimenopausal women 2018
- Levonorgestrel-releasing intrauterine device used for dysmenorrhea: five-year literature review 2014
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00